Skip to Main Content

Paper Details

<i>De novo</i> emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: A case report.
medRxiv
7
2021
B-cell deficiency, E802D, Remdesivir, SARS-CoV, SARS-CoV-2, SARS-CoV-2 infection, casirivimab, imdevimab, immunocompromised, nsp12 RNA-dependent RNA polymerase, patient, patients, remdesivir

Datasets